Company Poniard Pharmaceuticals, Inc. Other OTC
Equities
PARD
US7324494001
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Cancer Therapeutics
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,499,232 | 37,481 ( 2.500 %) | 0 | 2.500 % |
Stock B | 0 | 78,768 | 0 | 0 |
Company contact information
Poniard Pharmaceuticals, Inc.
300 Elliott Avenue West Suite 530
98119, Seattle
+
Sector
1st Jan change | Capi. | |
---|---|---|
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |